Skip to main content
BRLN logo
BRLN
(BATS)
iShares Floating Rate Loan Active ETF
$50.82-- (--)
Loading... - Market loading

BRLN ETF: iShares Floating Rate Loan Active ETF - Price, Holdings & Analysis

iShares Floating Rate Loan Active ETF Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Day's Range$50.75 - $51.07
52-Week High$52.59
52-Week Low$50.10
Open$50.91
Volume13.69K
Average Volume (3M)5.92K
Assets (AUM)53.86M
Expense Ratio0.55%
Total Holdings422
Inception DateOct 3, 2022
1 Day Change-0.21%
1 Month Change0.43%
6 Month Change-0.99%
YTD Change-1.10%
1 Year Change-1.13%
52-Week Change-1.32%
50-Day MA$50.86
200-Day MA$51.37
RSI52.81
Stochastic %K38.26
Stochastic %D45.51
Annual Dividend$3.53
Dividend Yield6.91%
Last Dividend Ex-DateJun 1, 2026
Dividend Growth YoY-7.99%

Frequently Asked Questions About iShares Floating Rate Loan Active ETF

What is the current price of BRLN?

The latest BRLN price is $51.07. The 52-week range is $50.10–$52.59. BRLN has returned -1.3% over the past 52 weeks.

What is the expense ratio for BRLN?

BRLN's annual expense ratio is 0.55%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Fixed Incomes in the ETF Screener.

Does BRLN pay dividends?

Yes, BRLN pays a 6.91% dividend yield. The last ex-dividend date was 2026-06-01. View full dividend history in the Dividends section.

What are the top holdings of BRLN?

BRLN's largest holdings are BlackRock Cash Funds Treasury SL Agency (11.5%), iShares Broad USD High Yield Corporate Bond ETF (3.7%), iShares Broad USD High Yield Corporate Bond ETF (3.4%) (combined weight: 18.7%). The fund holds 422 total positions. View the complete portfolio breakdown in the Holdings section.

How does BRLN compare to similar ETFs?

Compare BRLN (0.55% expense ratio, $54M AUM) against similar Fixed Incomes using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.